title: Vitamin D inhibition of lung adenocarcinoma cell proliferation in vitro.
abstract: Vitamin D has the capability to inhibit tumor cell proliferation and promote tumor cell apoptosis but whether this mechanism exists in lung adenocarcinoma cells remains to be studied. Our objective is to explore whether vitamin D has the capability to inhibit lung adenocarcinoma cell proliferation and synergize with cisplatin. Our method was to explore the effect of different concentrations of 1,25(OH)2D3 with or without cisplatin on lung adenocarcinoma cells by detecting cell proliferation rates at different time points. 1,25(OH)2D3 was capsulated with nanomaterial before acting on lung adenocarcinoma cells, and cell proliferation rates at different time points were detected with the CCK-8 method. When vitamin D was applied at a concentration of 1 × 10(-7) and 1 × 10(-6) mol/L on A549, PC9, SPC-A1, and H1650 cells for 72 h, no inhibition occurred on cell proliferation. Between the concentrations of 1 × 10(-5) and 0.5 × 10(-5) mol/L, inhibition on cell proliferation increased with drug action time. Between the concentration of 2.5 × 10(-5) and 0.03 × 10(-5) mol/L, inhibition on cell proliferation increased with increasing drug concentration. Analysis using bivariate correlations showed that the correlation coefficient of the proliferation inhibition rate and drug content was 0.580 (p < 0.0001). The correlation coefficient of proliferation inhibition rate and the drug action time was 0.379 (p = 0.01). The combined use of vitamin D and dichlorodiammine-platinum(II) (DDP) significantly increased the inhibition rate on A549 cell proliferation, which peaked after culturing for 96 h (Table 4). Further analysis using bivariate correlations showed that the correlation coefficient between proliferation inhibition rate and DDP concentration was 0.319 (p < 0.0001). The correlation coefficient of the proliferation inhibition rate and vitamin D concentration was 0.269 (p < 0.0001). The correlation coefficient of proliferation inhibition and drug action time was 0.221(p = 0.003). Vitamin D capsulated with nanomaterial (5 ng/ml) on PC-9 cells for 72 h did not inhibit cell proliferation, while after 10 days, the content of crystal violet dissolved decreased by 6.3 ± 3.2% for the nonleaded nanomaterial group and decreased by 45.8 ± 10.9% for the nanomaterial-capsulated vitamin D group (p < 0.0001). Vitamin D has the capability to inhibit the proliferation of lung adenocarcinoma cells, synergistically inhibit the proliferation of lung adenocarcinoma cells with DDP, and when capsulated with nanomaterial can significantly inhibit the proliferation of lung adenocarcinoma cells.
authors.affiliation: Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, West Huaihai Road 241, Shanghai, China, 200030.
authors.forename: Rong
authors.initials: R
authors.lastname: Li
authors.forename: Yuqing
authors.initials: Y
authors.lastname: Lou
authors.forename: Weiyan
authors.initials: W
authors.lastname: Zhang
authors.forename: Qianggang
authors.initials: Q
authors.lastname: Dong
authors.forename: Baohui
authors.initials: B
authors.lastname: Han
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology*; D000970:Antineoplastic Agents / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols; D049109:Cell Proliferation / Q000187:drug effects*; D002945:Cisplatin / Q000494:pharmacology*; D004357:Drug Synergism; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D014407:Tumor Cells, Cultured; D014807:Vitamin D / Q000494:pharmacology*; D014815:Vitamins / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D014815:Vitamins; D014807:Vitamin D; D002945:Cisplatin
references.citation: Semin Respir Crit Care Med. 2011 Feb;32(1):78-93
references.pmid: 21500127
references.citation: Clin Chem. 2013 May;59(5):771-80
references.pmid: 23503722
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):905-16
references.pmid: 23462913
references.citation: Am J Clin Nutr. 2008 Aug;88(2):565S-569S
references.pmid: 18689403
references.citation: Cancer Causes Control. 2012 Sep;23(9):1557-65
references.pmid: 22829430
references.citation: Clin Lung Cancer. 2013 Jul;14(4):433-9
references.pmid: 23522953
references.citation: Cell Cycle. 2013 Mar 1;12(5):743-52
references.pmid: 23388458
references.citation: Thorac Cancer. 2012 Nov;3(4):303-306
references.pmid: 28920282
references.citation: PLoS One. 2013;8(3):e58725
references.pmid: 23527013
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Nutrients. 2013 Jul 08;5(7):2577-89
references.pmid: 23857228